Detalhe da pesquisa
1.
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
Cancer Sci
; 113(4): 1531-1534, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839585
2.
Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel.
Am J Nephrol
; 53(4): 297-306, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325889
3.
CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
Cancer Sci
; 112(7): 2915-2920, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931919
4.
Circulating tumor DNA as a predictive biomarker in Merkel cell carcinoma.
J Am Acad Dermatol
; 87(5): 1209-1211, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318107
5.
Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection.
J Am Soc Nephrol
; 32(10): 2439-2441, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162734
6.
The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.
Int J Clin Oncol
; 20(1): 59-69, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24902933
7.
Genetic nondiscrimination.
Nat Genet
; 37(6): 559-60, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15920511
8.
Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy.
Front Oncol
; 13: 1170513, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251939
9.
Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma.
Commun Med (Lond)
; 3(1): 146, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37857666
10.
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.
Case Rep Oncol
; 15(2): 473-479, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702676
11.
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101943
12.
A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
J Heart Lung Transplant
; 41(7): 919-927, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577713
13.
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse.
Front Oncol
; 12: 786451, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35186734
14.
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant.
Case Rep Obstet Gynecol
; 2022: 9412201, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35342654
15.
Association Between Total Cell Free DNA and SARS-CoV-2 In Kidney Transplant Patients: A Preliminary Study.
Transplant Proc
; 54(6): 1446-1454, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618524
16.
Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant.
Transplant Direct
; 8(4): e1317, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35372675
17.
Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test.
Commun Med (Lond)
; 2: 29, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603292
18.
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.
JCO Precis Oncol
; 6: e2100181, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263168
19.
Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation.
Transplantation
; 106(8): 1690-1697, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289777
20.
ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden.
Case Rep Oncol
; 14(2): 849-853, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34248549